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ABSTRACT
Green synthesis of nanoparticles (NPs) using microorganisms and green plants is one of the latest trends in research 
that has gained momentum, since it is an ecofriendly approach, with lesser toxicity to the environment. Microbial 
synthesis of metal NPs is a function of the ability of resistance against heavy metal toxicity, carried out by redox 
enzymes that participate in converting toxic metal ions to inert forms, or by structural proteins that bind metals. Yeasts 
are non-pathogenic, eukaryotic microorganisms, and available in different strains which have economic importance 
in breweries and bakeries as well as in food industry as nutrient supplements and their ability to ferment sugar. A 
novel use of yeasts, explored in recent times, is their potentiality to produce metal (gold, silver, titanium, palladium, 
and selenium)-NPs, of specific dimensions, either extracellularly or intracellularly, through their reducing enzymes 
involving different mechanisms. Such synthesized NPs also have tremendous importance as antibacterial, antifungal, 
antioxidant, and anticancer agents. This review focuses on yeast as a major scaffold for synthesis of different metal NPs 
and their several biological applications including nanomedicines.
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INTRODUCTION
Nanotechnology has emerged as one of the popular 
technologies in recent times because of its significant 
influence in electronics, energy and space industries, 
pharmaceuticals, biomedical, environmental, and 
agricultural sectors. This technology is dependent on the 
synthesis and regulation of nanoparticles (NPs), which are 
small-sized particles of the dimension range of 0.1–100 
nm, exhibiting a range of desirable properties such as 
near identical strength (e.g., resistance to crushing), active 
surfaces with unusual catalytic properties, high surface-
to-volume ratio and discrete energy levels, and yielding 
fascinating tailoring of electronic properties.[1] NPs are 
classified on the basis of their morphology, dimensionality, 
composition, uniformity, and agglomeration. 
Nanomaterials can be compared with the size of cellular 
organelles such as nano-size proteins. They can target the 
desired sites leaving other cellular machinery uninterfered. 
With regard to their morphology, they are available in 
different forms such as nanoprisms, nanobelts, nanorods, 
nanoplates, nanospheres, nanocubes, and nanotetrapods. 
The size and shape of NPs dictate their functions, namely, 
better microbial activity or efficiency of drug delivery in 
the target site is exhibited by smaller NPs.[2] In addition, 
the composition of NPs is another important aspect, 
namely, silver-NPs (Ag-NPs) can be applied in a wide 
range of areas such as photonics, electronic and optical 
appliances, information storage, photovoltaics, photonics, 
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catalysts, diagnostics, therapeutics, and food storage.[3] 
NPs exist either naturally in biological systems such as 
bacteria, viruses, fungi, insect tentacles, spider silk, and 
human bones or in inorganic forms in nature such as 
cement, clay, opals, pigments, and so on.[4] They are 
quite regularly used, nowadays, in magnetic resonance 
imaging, tumor-therapy, gene therapy, and as antibacterial 
agents, biosensors, drug carriers in targeted delivery, 
nanopesticides, nanofertilizers, and DNA delivery in 
agriculture.[5] Nanomedicine aims to integrate modern 
nanotechnology with biotechnology and several molecular 
tools for curing diseases and repairing tissue damages for 
improving human health, generating novel drug delivery 
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systems, and developing ultrasensitive diagnostic tools 
such as implantable biomaterials, surgical aids, biosensors, 
and biopharmaceutical objects.
SYNTHESIS OF NPS: CHEMICAL VIS-À-VIS 
BIOLOGICAL
A major part of nanoscience research involves synthesis of 
NPs of different chemical composition, size, morphology, 
and monodispersity. Several physical, chemical, biological, 
and hybrid methods are available for NP synthesis, of 
which physical and chemical methods are more common, 
since they offer higher production rate in a relatively 
short time and better control over NP size. However, 
they suffer from several limitations such as anaerobic 
conditions, use of toxic reagents for synthesis, high energy 
requirement and capital investment, lack of stability, being 
outdated, and production of hazardous wastes that leads 
to substantial pollution, and human health problems. All 
these factors together limit their biomedical applications 
in clinical fields. The chemically-synthesized NPs are 
less biocompatible.[6] Therefore, there is an increasing 
need in developing nontoxic, environmentally-safe, 
ecofriendly, economical, and biocompatible protocols 
for NP synthesis. The current focus is to go for green 
synthesis of NPs from natural sources such as micro-
organisms, plants, microbial enzymes, polysaccharides, 
and biodegradable polymers. The biogenic process is not 
as energy-intensive as the chemical method, eliminates 
the use of expensive chemicals lowering the production 
cost and is environment-friendly. Moreover, particles 
generated by this process have greater specific surface 
area, higher catalytic reactivity and facilitates improved 
contact between the enzyme and metal salt.[7] NP catalysts, 
consisting of non-magnetic and magnetic materials, 
offer highly available active specific surface and foster 
microbiological reaction rates. The microorganisms, in 
particular, hold a special place in NP synthesis, since they 
can grab the target ions from the surrounding environment 
and convert them enzymatically into the element metal, 
either intracellularly (by transporting the ions within 
the cells and accumulating the NPs in the periplasmic 
space) or extracellularly (by trapping the metal ions on 
cell surface, and the reductive enzymes housed in the cell 
wall or soluble secreted enzymes are extruded out of the 
cell to cause reduction of metal ions).[8] Various categories 
of microbes such as magnetotactic bacteria, bacteria with 
S-layer, actinomycetes, and diatoms, fungi, including 
yeast and plants have high potentiality in generating 
nanostructured mineral crystals and metallic NPs with 
controlled shape, size, composition, and monodispersity 
of particles.[9] Microbes participate in biogeochemical 
cycles of metals through processes such as degradation 
(biocorrosion), decomposition (bioweathering), and 
precipitation (biomineralization), which are linked with 
distribution, mobilization, and chemical modification 
that control metal speciation and ultimate toxicity. 
Most metal ions are toxic to bacteria which trigger the 
bacterial defense machinery as a means of survival by 
undergoing ion bioreduction or the formation of water-
insoluble complexes, thereby leading to the accumulation 
of NPs of silver, gold, platinum, palladium, titanium 
dioxide, magnetite, and cadmium sulfide. Thus, bacteria 
are regarded as tiny but active biofactories for NP 
production.[10] Therefore, NP biosynthesis by microbes 
is a function of resistance mechanisms against heavy 
metal stress, whereby toxic heavy metals are converted 
to non-toxic species which undergoes precipitation to 
metal clusters of definite shape and nanoscale dimension. 
Microbial synthesis of NPs has actually merged different 
disciplines such as microbiology, biotechnology, and 
nanotechnology into a new field of nanobiotechnology.
YEAST AS THE SOURCE OF NPS
Mycosynthesis of NPs is considered to be more 
straightforward and easy for stable production of NPs 
as compared to bacteria. Fungi have several advantages 
over bacteria showing (i) higher biomass and easy mode 
of culture, (ii) higher bioaccumulation of metabolites, 
(iii) higher tolerance to, and uptake capability of metals, 
and (iv) high wall binding capacity of metals. Some of 
the enzymes have been found to play significant role in 
NP synthesis, such as reductase from Penicillium sp., 
nitrate reductase and NADPH-reductase from Fusarium 
oxysporum, along with electron shuttle quinones.[11]
Yeasts according to invention are classified in the 
kingdom Fungi, phylum Ascomycota, in subphylum 
Saccharomycotina, in the class Saccharomycetes, 
in the order Saccharomycetales, in the family 
Saccharomycetaceae, and in the genus Saccharomyces,[12] 
with about 1500 species currently described. 
Saccharomyces cerevisiae, known as “baker’s yeast”, can 
reside in diverse environmental niches. S. cerevisiae is 
probably the best studied of all the yeast species in terms 
of physiology and genetics, and definitely of immense 
industrial significance because of its involvement in 
fermentation of bread, beer, or wine. It is an ideal source 
of different enzymes and vitamins, considered as nutrient 
supplement and can treat antibiotic-related diarrhea.[13] 
Rapid growth and easy control of mass production of 
yeasts using simple nutrient culture medium altogether 
make yeast as the preferred microorganism for NP 
synthesis, as compared to other microbes. Yeast cells can 
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act as a template that induces biomineralization, which is 
the major mechanism for NP formation.[14]
One of the advantages of using yeast cells as 
NP-carriers is that simple encapsulation mechanism is 
possible using only yeast cells, water, and reagents, with 
no requirement of stabilizers. Yeast cells are, on the one 
hand, biomacromolecular microparticles having envelope 
composed of chitin, glycoproteins, and β-glucans, while, 
on the other hand, they are microcapsules, with plasma 
membrane helping in encapsulation so that yeast cells can 
encapsulate polymer NPs.[15,16] Intracellular formation of 
metal NPs occurs by reduction of metal salts, which can 
occur in three steps, that is, passive diffusion of metal 
salts present in aqueous solution into cells, removal of 
extracellular salts, followed by reduction mediated by 
transport of reducing reagents into cells.[17] Activation of 
membrane-bound oxidoreductases, through increasing the 
pH of the interior of yeast cell, leads to the reduction of 
metal ions, so that NPs are generated. Because of their 
strong nucleophilic and redox properties, quinones can 
also reduce metal ions, converting them to NPs.[18] The 
main purpose of NP biosynthesis is to eliminate NP toxicity 
through cellular defense mechanisms through compounds 
such as phytochelatins (PCs) and glutathione, which can 
not only bind metal ions but also show unique redox and 
nucleophilic properties essential for bioreduction of metal 
ions.[19]
Ag-NPs
Jha et al.[20] synthesized Ag-NPs by growing yeast cells in 
the form of a suspension culture in the presence of 0.025 
M AgNO3 solution and finally filtering the sooty gray NPs 
that were formed extracellularly. It was suggested that such 
synthesis occurred in the presence of a sulfate or nitrate 
reductase system, operating in the presence of ATP and 
NADH or anthraquinone. Alternately, PC binding to Ag 
forms Ag-PC complex which is transported into vacuole, 
where the complex is degraded to release Ag-NPs. 
Moreover, there occurs an electrostatic interaction between 
Ag+ and negatively charged COOH groups residing on 
specific enzymes, proteins, or polypeptides present on the 
cell wall. Mourato et al.[21] produced Ag-NPs with diameter 
smaller than 20 nm in extremophilic yeast strain from acid 
mine drainage, grown in the presence of AgNO3 up to 
1.5 mM. Zahran et al.[22] utilized three environment friendly 
strains of yeast fungi, namely, S. cerevisiae, Rhodotorula 
glutinis, and Geotrichum candidum for the extracellular 
biosynthesis of AgNPs (2.5–20 nm) by direct exposure 
to AgNO3 solution. Niknejad et al.[23] also demonstrated 
extracellular synthesis of fairly monodispersed, spherical-
shaped Ag-NPs, exhibiting high antifungal activity 
against some fluconazole-susceptible and fluconazole-
resistant strains of Candida albicans. Ganbarov et al.[24] 
also showed the synthesis of Ag-NPs by yeast strain, 
BDU-XR1 isolated from spontaneous yogurt used in 
Azerbaijan. The Ag-NPs, in this case, were detected by 
absorption wavelength of 410–420 nm in UV–visible 
spectrophotometer. Li et al.[25] produced Ag-NPs both at 
the cell wall and inside cells, depending on the preparation 
methods. Glucans on the cell wall functioned as reductive 
reagents in Tollens’ reaction (or silver-mirror reaction) to 
generate 9 nm Ag-NPs, while 4 nm NPs were produced 
inside the cells on UV illumination along with importing 
AgNO3 solution in cytoplasm. Tollens’ reaction usually 
occurs immediately upon addition of reducing reactants, 
and in this case formed thin films of Ag over the surfaces 
of yeast cells suspended in the reaction solution. Wilfred 
and Akin-Osanaiye[26] biosynthesized Ag-NPs which 
were characterized by UV-visible spectroscopy, showing 
a prominent absorption peak at 429 nm, attributed 
to plasmon resonance of Ag-NPs; scanning electron 
microscopy (SEM) which showed oval-shaped NPs; and 
Fourier-transform infrared, which revealed notable peaks 
at 3332.2, 2903.6, and 1636.3 cm, corresponding to the 
binding of the Ag-NPs to active biomolecules, namely, 
alcohols and phenols, carboxylic acids, and aromatic 
amines, respectively. The Ag-NPs, showing antibacterial 
activity, were found to be stable for 90 days. Very recently, 
Shu et al.[27] produced well-dispersed Ag-NPs of uniform 
spherical shape and average size of 13.8 nm, using yeast 
extract as reducing and capping agents. Yeast micelles 
were formed on mixing Ag+ solution with yeast extract. 
The bioreducing biomolecules such as carbohydrates, 
reductive amino acids, aminobutyric acid, and α-linolenic 
acid, which are in abundance in yeast extract, have a 
significant role in the reduction of Ag+ and of providing 
favorable stability, monodispersity, and controllable 
size distribution for the synthesized Ag-NPs. The amino 
acids located on the surface of Ag-NPs bear net negative 
charges which can maximize the electrostatically repulsive 
interactions in alkaline solution, and can, therefore, 
provide stability to the NPs without causing precipitation 
for more than a year.[27] Horstmann et al.[28] observed 
several differentially expressed genes through RNAseq-
based transcriptome analyses in yeast cells, treated with 
20 nm spherical citrate-coated Ag-NPs. Such genes were 
involved in the formation of cell wall, maintaining cell 
membrane integrity, biogenesis of ribosomes, processing 
of rRNA, and mitochondrial functions. The genes whose 
functions are associated with processing of ribosomal 
small and large subunits were up regulated, while genes for 
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maintaining the integrity of cell wall, plasma membrane, 
and mitochondria were downregulated.
Gold (Au)-NPs
Mourato et al.[21] produced Au-NPs with diameter ranging 
from 30 to 100 nm in extremophilic yeast strain from 
acid mine drainage, grown in thr presence of HAuCl4 up 
to 0.09 mM, above which there was a strong inhibitory 
effect. Promising results of Au-NP production were 
obtained by Gericke and Pinches[29] with the yeast, Pichia 
jadinii through exposure to HAuCl4. Another tropical 
marine yeast, Yarrowia lipolytica NCIM 3589 synthesized 
Au-NPs of 15 nm size at pH 7.0 and 9.0, when incubated 
with HAuCl4 solution, either using constitutively produced 
NADH and NADH-dependent reductases, or an enzyme 
(protease) for reducing Au-salts to NPs, which were 
mostly associated with and organized on cell wall.
Titanium di Oxide (TiO2)-NPs
Peiris et al.[30] synthesized anatase TiO2-NPs of <12 nm by 
incubating yeast suspension in TiCl3 using the surface of 
yeast cells as the site for Ti3+ nucleation. The yeast cells 
remain attached together during nucleation, and a porous 
lamellar structure containing TiO2-NPs is formed during 
high temperature treatment, when yeast cells are removed, 
spilling over CO2 gas and forming a unique lamellar 
mesophase structure. The redox reaction-mediated 
biosynthesis of TiO2 NPs occurs by reducing agents 
such as urease, glucose, and α amylase in the medium. 
The NPs were characterized by several biophysical 
techniques such as X-ray diffraction, scanning electron 
microscopy, transmission electron microscopy, UV-visible 
spectroscopy, and energy dispersive X-ray analysis studies.
Selenium (Se)-NPs
Faramarzi et al.[31] have very recently produced Se-NPs in 
yeast by adding increasing amounts of sodium selenite in 
the culture medium, when the Se ions could be effectively 
reduced in selected amounts, leading to NP formation. 
However, minimum amount of sodium selenite led to more 
stable Se-NP formation with minimum particle, due to the 
higher amounts of reducing and stabilizing agents of the 
biomass. The fabricated Se-NPs, formed intracellularly, 
possessed particle size, polydispersity index, and zeta 
potential ranging from 75 to 709 nm, 0.189 to 0.989, and 
−7.06 to −10.3 mV, respectively. However, most uniform 
Se-NPs were formed using maximum amount of selenium 
salt (25 μg).
Palladium (Pd)-NPs
Li et al.[25] synthesized aggregated Pd-NPs of about 11 nm 
size which was distributed almost evenly in cell envelope 
and cytoplasm of yeast cells, since Pd ions do not have 
strong interactions with cellular materials. The first 
step involved the addition of saturated toluene solution 
of palladium acetate into the aqueous cell suspension, 
allowing oil droplets to diffuse into the cells. Palladium 
acetate external to yeast cells was washed away by 
filtration using ethanol. At the second step, hydrazine 
hydrate was added to the yeast cell suspension to reduce 
Pd ions.
EXTRACTION OF NPS
NPs produced intracellularly or extracellularly should be 
purified from the yeast strain. Centrifugation or dialysis 
from media enables extraction of extracellularly-produced 
NPs. In case of intracellularly-produced NPs, yeast strains 
should be lyzed chemically or physically.[32] Care should 
be taken so that there is no NP degradation or aggregation 
and yield is minimized. The extraction procedure should 
be carefully standardized to derive pure, stable, and highly 
effective NPs for various applications.
BIOLOGICAL APPLICATIONS OF NPS 
FROM YEAST
Metal NPs are considered as a promising and low-cost 
antimicrobial agent. Yeast cells carrying NPs can easily 
activate the phagocytosis process. Se-NPs, known as 
new generation drug, are important in medicines due 
to their antioxidant, anti-inflammatory, antimicrobial, 
and anticancer properties. The antioxidant activity of 
the Se-NPs was also established, being maximum at the 
lowest concentration of sodium selenite (5 μg) in the 
culture medium.[31] The patented sulfur-free Se-NP from 
yeast has been applied in medical field and fermentation 
industries. Both Se-NPs and Ag-NPs are considered as 
substitution agents for antibiotics. Shu et al.[27] observed 
that the yeast-synthesized Ag-NPs, when applied with 
ampicillin, exhibited significant antibacterial activity 
in a concentration-dependent manner by reversing the 
resistance property in ampicillin-resistant Escherichia 
coli cells. The surface coatings on Ag-NPs enhanced the 
affinity toward bacterial membrane by increasing the cell 
wall permeability. The configuration of the peptidoglycan 
was changed as a result of its interaction with Ag-NPs that 
finally led to the apoptosis of bacterial cell. Thus, it was 
predicted that these monodispersed Ag-NPs could have a 
promising role in the disinfection of multidrug-resistant 
bacterial strains. The Ag-NPs are also components 
of medical devices such as catheters, implants, and 
prostheses. The TiO2-NPs were found to exhibit strong 
antimicrobial activity against Gram-positive bacteria 
(Staphylococcus aureus) and C. albicans, when compared 
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to Gram-negative bacteria (Pseudomonas aeruginosa 
and E. coli), both in the presence and absence of sunlight 
exposure.[30] Nowadays, the NPs also find application in 
the field of fermentation industry. Yeast strains which 
are used in fermentation processes could produce NPs as 
an effective defense against pathogenic microorganisms 
or contaminating bacterial strains which jeopardize the 
fermentation process, for example, Ag-NPs produced 
by yeast can control contaminating bacteria such as 
Lactobacillus fermentum, Lactobacillus brevis, and 
Pediococcus pentosaceus in a fuel ethanol fermentation 
production process. Pd-NPs are the catalysts for the 
Suzuki reactions. Yusop et al.[33] succeeded in importing 
Pd-NPs within HeLa cells for undergoing a Suzuki 
reaction. Au-NPs have been applied in angiogenesis and 
tumor detection, as well as for the specific delivery of 
drugs, such as paclitaxel, methotrexate, and doxorubicin.
CONCLUSION AND FUTURE 
PERSPECTIVES
Although yeasts have been shown to serve as ideal vehicles 
for production of NPs of different metals, the number 
of studies conducted in this field is quite inadequate. 
The biological production of NPs by yeast is still in its 
infant stage. Much works need to be done to improve the 
efficiency of synthesis, reduce the production time and 
optimize the control of particle size, morphology and 
monodispersity, by standardization of different parameters 
such as target NP, growth medium, synthesis conditions, 
pH, substrate concentrations, and temperature. The 
stability of the synthesized NPs for a longer duration is 
to be ensured. Understanding the synthesis mechanism at 
the cellular and molecular level, especially with regard to 
genome and proteome analyses is also necessary. The yet-
uncharacterized functional reducing agents and enzymes 
released by yeasts to convert the harmful ions into non-
harmful particles may have a definite role in NP synthesis. 
More focus is demanded with regard to extracellular 
synthesis of NPs over intracellular ones, since additional 
operations such as chemical reactions and ultrasound 
operations are eliminated in the former. Moreover, NP 
synthesis by yeasts or any microbes is still at the laboratory 
scale so that scale-up of NP production should be 
emphasized to meet the demand for practical applications. 
Another much-awaited usability of yeast-synthesized NPs 
which remain to be fully investigated is their potentiality 
in fermentation industry. This will actually mark the 
importance of nanotechnology in fermentation industry, in 
addition to their applications in medical sectors, which is 
mostly examined by research groups. Synthesizing NPs by 
biological means, which has the advantages of non-toxicity, 
reproducibility in production, easy scaling-up, and well-
defined morphology, will continue to become a common 
trend in NP production in the forthcoming years.
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